Karel Berkhout covers the publication of the Access to Vaccines Index 2017, in particular referring to the development of new vaccines against ebola and malaria.
In the article, he writes : “After years of stagnation, many affordable vaccines for poor countries are in development. Pharmaceutical companies have gone a long way toward the development of vaccines for ebola and malaria, while the first vaccine for dengue has been approved.”
